2017
DOI: 10.1016/j.ejso.2017.10.157
|View full text |Cite
|
Sign up to set email alerts
|

Metastatic colorectal cancer (mCRC) patient derived organoids (PDOs) as a preclinical tool to understand mechanisms of resistance to anti-angiogenic drugs

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles